Wrasse Pharmaceuticals Private Limited
Pharmaceutical company that manufactures, formulates, and trades various healthcare products and medicines.
2018 | Haridwar, Uttarakhand (India) | Active
Wrasse Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth 19.06%
- Ebitda 28.64%
- Net Worth -2.57%
- Total Assets -4.28%
About Wrasse Pharmaceuticals
Wrasse Pharmaceuticals Private Limited (WPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 July 2018 (Six years and seven months 11 days old ). Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ashish Virmani, Ankit Gulati, Mansi Virmani, and One other member serve as directors at the Company.
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999UR2018PTC008900
- Company No.
008900
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Pharma
Who are the key members and board of directors at Wrasse Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Virmani  | Director | 20-Jul-2018 | Current |
| Ankit Gulati | Director | 20-Jul-2018 | Current |
| Mansi Virmani | Director | 20-Jul-2018 | Current |
| Jasmeet Luthra | Director | 20-Jul-2018 | Current |
Financial Performance of Wrasse Pharmaceuticals.
Wrasse Pharmaceuticals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 19.06% increase in profit. The company's net worth dipped by a decrease of 2.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wrasse Pharmaceuticals?
In 2021, Wrasse Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zaneka Pharmaceuticals Private LimitedAshish Virmani is a mutual person
Zaneka Healthcare LimitedAshish Virmani is a mutual person
- Farma Hub Overseas Private Limited
Ashish Virmani and Mansi Virmani are mutual person
- Atisun Biosciences Private Limited (Opc)
Ankit Gulati is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wrasse Pharmaceuticals?
Unlock and access historical data on people associated with Wrasse Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wrasse Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wrasse Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.